Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oldham

Showing results (471-480 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Psychiatry|February 2, 2002
Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorderAndrew E Skodol, John G Gunderson, Thomas H McGlashan, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The European Respiratory Journal|August 17, 2023
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung diseaseDavid Zhang, Ayodeji Adegunsoye, Justin M Oldham, et al.
Pulmonary Circulation|December 24, 2015
Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practiceNatalia C Berry, Agarwal Manyoo, William M Oldham, et al.
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Chest|October 2, 2017
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease CohortAyodeji Adegunsoye, Justin M Oldham, Jonathan H Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variantsRitah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
The European Respiratory Journal|May 5, 2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysisAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
The Lancet. Respiratory Medicine|January 22, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysisWillis S Bowman, Chad A Newton, Angela L Linderholm, et al.
Pageof 57

Showing results (471-480 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Psychiatry|February 2, 2002
Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive-compulsive personality disorderAndrew E Skodol, John G Gunderson, Thomas H McGlashan, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
The European Respiratory Journal|August 17, 2023
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung diseaseDavid Zhang, Ayodeji Adegunsoye, Justin M Oldham, et al.
Pulmonary Circulation|December 24, 2015
Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practiceNatalia C Berry, Agarwal Manyoo, William M Oldham, et al.
Chest|October 22, 2023
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary FibrosisJohn S Kim, Shwu-Fan Ma, Jennie Z Ma, et al.
Chest|October 2, 2017
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease CohortAyodeji Adegunsoye, Justin M Oldham, Jonathan H Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
Cross-ancestry evaluation of idiopathic pulmonary fibrosis genetic risk variantsRitah Nabunje, Beatriz Guillen-Guio, Tamara Hernandez-Beeftink, et al.
The European Respiratory Journal|May 5, 2018
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysisAyodeji Adegunsoye, Justin M Oldham, Shashi K Bellam, et al.
The New England Journal of Medicine|May 19, 2025
Nerandomilast in Patients with Idiopathic Pulmonary FibrosisLuca Richeldi, Arata Azuma, Vincent Cottin, et al.
The Lancet. Respiratory Medicine|January 22, 2022
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysisWillis S Bowman, Chad A Newton, Angela L Linderholm, et al.
Pageof 57